www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
China / Society

Police close investigation of GSK bribery

(Xinhua) Updated: 2014-05-14 11:46

CHANGSHA - The bribery investigation of GlaxoSmithKline (GSK) China is complete and the case has been handed over to prosecutors, Changsha police said on Wednesday.

Prosecutors have started their examination of the case that involves a total of 46 suspects, with Mark Reilly, a British national and manager of GSK China, among them. After ten months of investigation, police found that Reilly had ordered his subordinates to offer bribes.

Reilly allegedly pressed his sales teams to bribe hospitals, doctors, other medical institutions and organizations through various means and gained illegal revenue worth billions.

Reilly became head of prescription drugs at GSK China in Jan. 2009 and was promoted to general manager of GSK China in Nov. 2012. Two other executives, Zhang Guowei and Zhao Hongyan, are also suspected of bribing officials in Beijing and Shanghai to escape investigation.

Bigger bribes bring better sales

To boost sales and squeeze out rival companies, GSK China allegedly bribed doctors to prescribe their drugs. Li, one of the suspects in the case and doctor at a Hunan hospital, told Xinhua that in March 2012, a GSK sale representative offered him 20 yuan (3 US dollars) for every box of Heptodin he prescribed and 100 yuan for every new patient who started using the drug. Heptodin is used to treat Hepatitis B.

Li normally prescribed 150 to 200 boxes of Heptodin and recruited five to eight new patients each month, which brought him about 4,800 yuan of extra income. Tan would register the expense as payment for Li lecturing in the company's training programs.

"I paid him every month but in fact he just gave lectures once or twice," said Tan.

Another way to bribe doctors is to cover the expenses of attending medical seminars.

Zhang Guowei, a key suspect who was vice president and human resources director of GSK China, told Xinhua that the focus on sales growth led to the bribery.

"The global headquarters imposed high sales growth targets. When Reilly took over the post, the company's strategy shifted from profit-oriented to sales-oriented. The sales target in China was raised every year to compensate the reduction in U.S. and European markets," Zhang said.

According to Guo Jianhua, a human resources manager also involved in the case, the company's sales force increased from about 1,000 in 2008 to 5,500 today.

Police found that the company forced its sales team to bribe to achieve their soaring sales targets.

Liang Hong who was the company's vice president and operations manager, confirmed that those who met sales targets received big bonuses, promotions and overseas vacations while those who failed were demoted or fired.

In a statement to police, Liang said every representative was allowed to spend 3,000 to 5,000 yuan on kickbacks to doctors. "If this was not enough, they could apply for more. For hepatitis medicines, the kickback can account for five to eight percent of the drug's price," he said, but for other drugs might be as much as 30 percent and total hundreds of million yuan.

GSK China's revenue in China increased from about 3.9 billion yuan in 2009 to 6.9 billion yuan in 2012.

According to police, Reilly and his colleagues disguised illegal revenue in the Chinese market by forging transactions between GSK China and several foreign arms of GSK, making the revenue look like funds used to purchase raw materials in China. They made every effort to cover up the illegal practice during regular checks by regulatory authorities. In terms of sales of prescription drugs and vaccines, police found that all pharmaceutical factories and departments of GSK China nationwide had been involved in commercial bribery.

Last July, police detained four senior executives of GSK China on suspicion of commercial bribery. Reilly was not among them.

Police close investigation of GSK bribery

Police close investigation of GSK bribery

GSK's China sales may be down 30% on bribery scandal

Police reveals more about GSK China's violations

Highlights
Hot Topics
...
主站蜘蛛池模板: 亚洲精品免费观看 | www色在线| 性高湖久久久久久久久 | 99久久一区二区精品 | 免费观看一级成人毛片 | 久久久精品久久视频只有精品 | 男女很舒服爽视频免费 | 一区二区三区不卡视频 | 美女网站免费观看视频 | 亚洲欧美日韩另类在线 | 日韩精品国产一区 | 伊人蜜桃| 日本免费人成黄页网观看视频 | 一区二区三区在线视频观看 | 91国偷自产一区二区三区 | 日本韩国一级毛片中文字幕 | www.色黄| 色偷偷在线刺激免费视频 | 亚洲精品美女视频 | 国产成人夜间影院在线观看 | 欧美另类69xxxxx 视频 | 91香蕉视频成人 | 欧美日韩高清不卡免费观看 | 日本在线观看不卡 | 加勒比综合在线 | 91精品人成在线观看 | 亚洲资源在线播放 | 国产免费一区二区在线看 | 亚洲久久网 | 久久精品国产第一区二区 | 国产一级片视频 | 国产亚洲精品自在线观看 | 久久久久久91香蕉国产 | 亚洲天堂视频一区 | 毛片在线播放网站 | 97在线视频免费观看 | 美女一级片| 国产a国产片国产 | 91精品免费看 | 日韩欧美在线一区二区三区 | 乱码在线中文字幕加勒比 |